Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Novartis AG (NVS) ADR Call Rep 1 Ordinary CHF 20 (Reg) (CDI)

Sell:$84.89 Buy:$84.93 Change: $2.50 (3.03%)
Market closed |  Prices as at close on 12 August 2020 | Switch to live prices |
Sell:$84.89
Buy:$84.93
Change: $2.50 (3.03%)
Market closed |  Prices as at close on 12 August 2020 | Switch to live prices |
Sell:$84.89
Buy:$84.93
Change: $2.50 (3.03%)
Market closed |  Prices as at close on 12 August 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Novartis AG is a holding company, which provides healthcare solutions. The Company is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. The Company's segments include Innovative Medicines, Sandoz, Alcon and Corporate activities. Innovative Medicines researches, develops, manufactures, distributes and sells patented prescription medicines to develop health outcomes for patients and healthcare providers. Sandoz develops, manufactures, distributes and sells prescription medicines, as well as pharmaceutical active substances that are not protected by valid and enforceable third-party patents. Alcon researches, develops, manufactures, distributes and sells eye care products. Alcon is a provider of eye care with product offerings in eye care devices and vision care. The Company's range of products includes pharmaceuticals and oncology medicines, generic and biosimilar medicines, and eye care devices.

Contact details

Address:
Lichtstrasse 35
BASEL
4056
Switzerland
Telephone:
+41 (61) 3241111
Website:
https://www.novartis.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
NVS
ISIN:
US66987V1098
Market cap:
$204.14 billion
Shares in issue:
2.29 billion
Sector:
Pharmaceuticals
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Vasant Narasimhan
    Chief Executive Officer, Member of the Executive Committee
  • Harry Kirsch
    Chief Financial Officer, Member of the Executive Committee
  • Steven Baert
    Chief People & Organization Officer, Member of the Executive Committee
  • Steffen Lang
    Global Head of Novartis Technical Operations, Member of the Executive Committee
  • Klaus Moosmayer
    Chief Ethics, Risk and Compliance Officer, Member of the Executive Committee
  • Shannon Klinger
    Group General Counsel, Member of the Executive Committee
  • Bertrand Bodson
    Chief Digital Officer, Member of the Executive Committee
  • James Bradner
    President of the Novartis Institutes for BioMedical Research (NIBR), Member of the Executive Committee
  • Richard Saynor
    Chief Executive Officer of Sandoz, Member of the Executive Committee
  • Susanne Schaffert
    CEO Novartis Oncology, Member of the Executive Committee

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.